Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
NCT01525641
·
clinicaltrials.gov ↗
COMPLETED
Status
615
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Mirapex LA
Sponsor
Boehringer Ingelheim